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Abstract
High fat diet (HFD) is prevalent in many modern societies and HFD-induced metabolic condition is a growing concern
worldwide. It has been previously reported that HFD clearly worsens cognitive function in amyloid precursor protein (APP)
transgenic mice. On the other hand, we have demonstrated that voluntary exercise in an enriched environment is an
effective intervention to rescue HFD-induced b-amyloid (Ab) deposition and memory deficit. However, it had been unclear
whether consumption of HFD after exercising abolished the beneficial effect of exercise on the inhibition of Alzheimer’s
disease (AD) pathology. To examine this question, we exposed wild type (WT) and APP mice fed with HFD to exercise
conditions at different time periods. In our previous experiment, we gave HFD to mice for 20 weeks and subjected them to
exercise during weeks 10–20. In the present study, mice were subjected to exercise conditions during weeks 0–10 or
weeks 5–15 while being on HFD. Interestingly, we found that the effect of exercise during weeks 0–10 or weeks 5–15 on
memory function was not abolished in WT mice even if they kept having HFD after finishing exercise. However, in APP
transgenic mice, HFD clearly disrupted the effect of exercise during weeks 0–10 or weeks 5–15 on memory function.
Importantly, we observed that the level of Ab oligomer was significantly elevated in the APP mice that exercised during
weeks 0–10: this might have been caused by the up-regulation of Ab production. These results provide solid evidence that
continuation of exercise is necessary to rescue HFD-induced aggravation of cognitive decline in the pathological setting of
AD.
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Introduction
Alzheimer’s disease (AD), the occurrence of which is largely
sporadic, is characterized by deficits in memory and other
cognitive functions. Amyloid plaque is one of the pathological
hallmarks of AD and it is composed of b-amyloid (Ab). Ab is
derived from the amyloid precursor protein (APP) via proteolytic
cleavages by b- and c-secretases. Ab, in turn, is degraded by
several Ab-degrading enzymes including neprilysin or insulin-
degrading enzyme. A widely accepted hypothesis about AD
pathogenesis is the amyloid cascade hypothesis, in which Ab plays
a crucial role as an upstream molecule in neurodegeneration [1].
Considering that Ab accumulation is clearly observed almost a
decade before cognitive impairment is seen in AD patients [2,3],
there is growing consensus that prevention of AD at the earliest
stage is desirable.
Metabolic conditions including obesity and diabetes mellitus are
becoming severe problems. In modern society, the spread of high
caloric diet including high fat diet (HFD) may be the critical cause
of metabolic abnormalities. Of course, metabolic conditions are
known risk factors of vascular dementia but they could also risk
factors of sporadic AD [4–6]. It has been consistently seen that
feeding HFD to APP transgenic mice worsens the pathological
alterations of Ab metabolism and memory impairment [7]. On the
other hand, the paradigm of environmental enrichment has been
frequently used in experiments wherein mice can conduct exercise
voluntarily in a larger cage, with complex stimuli (e.g., running
wheels, toys), thus being provided with more physical and
intellectual stimulation than mice housed in standard conditions
[8,9]. Recently, we set up an enriched condition focused on
physical stimulation and demonstrated that voluntary exercise
inhibits HFD-induced Ab deposition and memory deficit in APP
transgenic mice [10]. More importantly, we have shown that
voluntary exercise is more effective than diet control in our
experimental setting [11]. Consistent with our results, many
reports support the theory that physical activity is closely
associated with a decreasing risk of cognitive impairment and
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that exercise is an effective strategy to prevent development of AD
[12–15].
Considering that metabolic condition is a growing issue
worldwide, we wondered whether continuing to have HFD after
exercising would abolish the beneficial effect of exercise on
memory function. In the present study, we demonstrated that the
effect of exercise on memory function was not abolished in WT
mice even if they kept having HFD after finishing exercise.
However, the exercise-induced improvement of memory was
clearly disrupted in APP transgenic mice. We showed that
consumption of HFD after exercising increased the level of Ab
oligomer in APP transgenic mice. Besides, we speculated that the
development of Abpathology might have been caused by increase
in Abproduction due to HFD. The results indicated that HFD
after finishing exercise might immediately worsen AD pathology,
and later disrupt the effect of exercise on memory function.
Therefore, continuation of exercise is necessary to inhibit HFD-
induced cognitive impairment in the pathological setting of AD.
Methods
Ethics statement
All animal experiments in this study were performed with the
approval of the Animal Experiment Committees of Kyoto
University, Graduate School of Medicine (Permit Number:
09597). All experiments were conducted in strict adherence to
the relevant international guidelines. Every effort was made to
minimize suffering of the animals.
Animals, dietary and exercise conditions
WT (C57BL/6 J) mice were obtained from Charles River
Laboratories Japan, Inc. (Japan). Human APP transgenic mice
(J20 mice) overexpressing familial AD-linked mutations bearing
both Swedish (K670N/M671L) and Indiana (V717F) mutation
were imported from the Jackson Laboratory (USA) [16]. They
were maintained as heterozygotes. Since HFD worsened memory
deficit and Ab deposition in female APP transgenic mice better
than in male (unpublished observation), female mice were used in
these experiments. To establish APP transgenic mice fed with
HFD (APP-HFD mice), age matched female were exposed to an
established HFD (caloric composition, 60% fat, 20% carbohy-
drate, and 20% protein, Research Diet, Inc., Canada) for
20 weeks, from 2–3 to 7–8 months of age. As a control diet,
female APP transgenic mice were exposed to a standard diet (10%
fat, 70% carbohydrate, and 20% protein, Oriental Yeast Co., Ltd.,
Japan). In voluntary exercise (Ex) condition, a cage was changed to
an enriched environment which was a 2.4 times larger than the
standard cage, and was equipped with a running wheel (12 cm in
diameter), toys and a stand. To examine the effects of exercise at
different periods on APP-HFD mice, female APP-HFD mice spent
weeks 0–10 (APP-HFD+Ex 0–10 mice, n = 8) or weeks 5–15
(APP-HFD+Ex 5–15 mice, n= 7) in exercise conditions in the
presence of HFD. As a control, we used female APP-HFD mice
which spent weeks 10–20 (APP-HFD+Ex 10–20 mice, n= 6) in
exercise conditions which we had previously established [10]. In
the experiments of metabolic analyses and memory test, we
examined the effect of exercise at different periods on WT mice
fed HFD (WT-HFD mice), using the same paradigm (n= 5, each
group). In order to examine the running length per day, we
monitored the number of running wheel rotations and estimated it
as follows:
n (the number of running wheel rotations)612 (cm/diameter)
63.14.
After dietary and motile manipulations, metabolic changes in
these mice were analyzed, which was followed by assessment of
memory function through Morris water maze test, as described
below. After the analysis of memory function, brains were
extracted and cut sagitally into left and right hemispheres.
Tribromoethanol was used for anesthesia in the surgical proce-
dures. The left hemisphere was fixed in 4% paraformaldehyde for
histological analysis. After removing the olfactory lobe and the
cerebellum, the right hemisphere was rapidly frozen in liquid
nitrogen for biochemical analysis.
Assessment of metabolic changes
Blood was collected from the tail-vein. To assess glucose
intolerance in these mice, we conducted intra-peritoneal glucose
tolerance test (IGTT). Mice were given a single intra-peritoneal
injection of glucose (2 g/kg body weight) after 14 hours fasting,
and blood was collected periodically over 2 hours (fasting, 30 min,
60 min and 120 min). Plasma glucose content was measured by
using LabAssay Glucose (Wako, Japan). Plasma insulin concen-
tration was measured by enzyme-linked immunosorbent assay
(ELISA) kit specific to insulin (Morinaga Seikagaku, Japan).
Morris water maze test
In order to assess spatial navigation learning and memory
retention, Morris water maze test was conducted using a pool of
water (diameter 120 cm, height 25 cm, temperature 2161uC).
Visual cue phase. Visible platform training was performed
to measure the motivation and swimming speed of mice to find a
platform. Distal cues were removed from around the pool, and the
platform was labeled with a flag and placed 1 cm above the
surface of the water in the center of a quadrant. Mice were placed
in the maze and allowed to explore the maze for 60 sec; if they
reached the visible platform, they were allowed to remain there for
20 sec before being returned to their cages. If they did not find the
platform within 60 sec, the experimenter led them to the platform
and let them remain there for 20 sec. The training was completed
once each animal received six trials. This training was performed
for 1 day.
Acquisition phase. We measured the ability of the mice to
understand the spatial relationship between a safe, but invisible
platform of 10 cm diameter (submerged 1 cm below water level),
and visual cues surrounding the maze. The platform was located in
the center of one of the four quadrants, and several extramaze cues
were distributed across the walls surrounding the pool. During the
acquisition phase of training, each mouse received four daily
hidden platform training trials with 12 min intervals for 5
consecutive days. The animals were allowed 60 sec to locate the
platform and 20 sec to rest on it. The mice that failed to find the
platform were led there by the experimenter and allowed to rest
there for 20 sec.
Probe trial phase. A day after the last acquisition trial, a
single 60 sec probe trial was administered to assess spatial memory
retention. For the probe trial, the animals were returned to the
pool without the platform present, and the parameters were
recorded to assess the ability of the mouse to remember the
previous location of the platform.
Performance was recorded with an automated tracking system
(ANY-maze, Brain Science. Idea. Co., Ltd., Japan) during all the
phases of training. During the visual cue phase of training, the
speeds at which the mice reached to the platform were used to
compare the activity of the performance among each group.
During the acquisition phase, time to goal (latency to reach the
platform) was subsequently used to analyze and compare the
performance between the different treatment groups. The time
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taken to get to the position where platform presented and the time
spent in goal quadrant were analyzed during the probe trials.
Measurement of Ab by ELISA
In order to prepare the samples for detection of Ab, mice
cerebrums were homogenized with Tris buffer saline (TBS) with
protease inhibitor cocktail (Roche, Germany). The homogenate
was centrifuged at 100,000 g for 1 hour, and the supernatant was
collected as the TBS-extracted fraction. The pellet was washed in
TBS and centrifuged at 100,000 g for 1 hour. Seventy percent
formic acid (FA) was added to the pellet, which was homogenized
again. The homogenate was incubated for 1 hour at 4uC and then
centrifuged at 100,000 g for 1 hour at 4uC. The resultant
supernatant was collected as the FA-extracted fraction, which
was neutralized with a 20-fold volume of 1 M Tris buffer
(pH 11.0).
The levels of Ab 40 and Ab 42 in FA fraction, or Ab oligomer in
TBS fraction were measured using ELISA kits specific to Ab 40,
Ab 42, or Ab oligomer (82E1-specific) (Immuno-Biological
Laboratories Co., Ltd., Japan), and in accordance with the
manufacturer’s instructions. We used a standard format for
measuring monomeric Ab species with the use of C-terminal
capturing antibodies and N-terminal or mid-region detecting
antibodies. To detect Ab oligomer species, the same N-terminal
antibody, 82E1 (to Ab residues 1–16, Immuno-Biological Labo-
ratories, Inc, USA), was used for both capture and detection.
Immunoblotting and filter trap assay
For immunoblotting analysis, mice cerebrums were extracted in
radio-immunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl,
150 mM NaCl, 1% Triton X100, 1% NP-40, 0.5% Deoxycholate,
0.1% SDS, pH 8.0) with protease inhibitor cocktail and
sufficiently homogenized on ice. The samples were incubated for
one night at 4uC and centrifuged at 14,000 g for 20 min. The
supernatants were directly used for Western blot analysis. The
detailed protocol has been described previously [10,11]. In the
previous experiments, we had used two types of gels (5–20%
polyacrylamide gradient gels (Atto, Japan) and 4–12% NuPAGE
Bis-Tris gel (Invitrogen, USA)) and two types of antibodies (rabbit
polyclonal anti-APP C-terminal antibody and mouse monoclonal
6E10 antibody). Since the experiment using 4–12% NuPAGE Bis-
Tris gel and rabbit polyclonal anti-APP C-terminal antibody was
the most quantitative, the same as used in the present study.
Rabbit polyclonal anti-APP C-terminal antibody was obtained
from SIGMA.
Filter trap assay was conducted as described previously [11].
Briefly, the protein concentration of the cerebrum samples in
TBS-extracted fraction was measured and an equal amount of
protein was subjected to vacuum filtration through a 96-well dot
blot apparatus (Bio-Rad Laboratories, USA) containing 200 nm
pore-sized nitrocellulose membrane. The membrane was then
incubated with the primary antibody at 4uC overnight. It was then
blocked by TBS containing 4% skimed milk, and incubated with
HRP-linked secondary antibody (GE Healthcare, UK; diluted
1:2000) for 1 hour. Next, it was developed using the ECL Western
Blotting Analysis System (GE Healthcare). Anti-oligomer antibody
(A11, Invitrogen) was used for the detection of Ab oligomer in the
TBS soluble fraction.
Immunohistochemistry
The paraformaldehyde-fixed and paraffin-embedded tissue
sections of mice were deparaffinized and rehydrated. The antigens
of tissue sections were activated by autoclave for 10 minutes in
10 mM citrate buffer (pH 6.0). Endogenous peroxidase activity
was suppressed by 0.6% hydrogen peroxide. Thereafter, tissue
sections were blocked by horse serum and incubated with primary
antibodies for 1 hour. The sections were then incubated with
Histofine Simple Stain MAX PO (Nichirei Corporation, Japan) for
1 hour. Subsequently, the labeling was visualized by incubation
with a solution of 3,3-diaminobenzidine (Merck & Co., Inc, USA)
with hydrogen peroxide. All images were visually analyzed using a
microscope, ECLIPSE 80i (Nikon Corporation). Anti-Ab (6E10)
antibody (1:200; SIGMA) was used for the detection of Ab plaque.
Neprilysin activity assay
The proteolytic activity of neprilysin was measured as described
previously but with minor modifications [17]. Briefly, mice
cerebrums were extracted in RIPA buffer and protein concentra-
tions were analyzed. 25 mg of extracted samples were incubated
with 50 mM substrate3-dansyl-D-Ala-Gly-p-(nitro)-Phe-Gly
(DAGNPG) (SIGMA) and 1 mM captopril- angiotensin converting
enzyme (ACE) inhibitor- in 200 ml of 50 mM Tris-HCl buffer
(pH 7.6) for 1 hour at 37uC. Reactions were stopped by heating
samples to 100uC for 5 min, followed by 5,000 g65 min
centrifugation. The 180 ml of supernatant was diluted into
400 ml of 50 mM Tris-HCl buffer (pH 7.6) and fluorescence was
determined using Infinite 200 PRO (Tecan Japan Co., Ltd.,
Japan) (excitation 342 nm, emission 562 nm).
Statistical analysis
All values are given in means 6 SE. Comparisons were
performed using an unpaired Student’s t-test. For comparison of
multiparametric analysis, we used one-way factorial ANOVA,
followed by a post-hoc analysis using Bonferroni post-hoc test.
Statistical significance of differences between mean scores during
IGTT and acquisition phase of Morris test were assessed with two-
way repeated-measures ANOVA (general linear model/RM-
ANOVA) and Bonferroni post-hoc analysis for multiple compar-
isons. The value p,0.05 was considered to indicate a significant
difference.
Results
Effects of exercise at different periods on the metabolic
conditions in APP-HFD mice
In our previous experiment, we fed APP transgenic mice with
HFD for 20 weeks and the mice were subjected to exercise
conditions during weeks 10–20 [10]. However, in the present
study, we exposed APP-HFD mice to exercise conditions at
different periods: weeks 0–10 (APP-HFD+Ex 0–10 mice) and
weeks 5–15 (APP-HFD+Ex 5–15 mice) (Figure 1). The increase of
body weight was suppressed during exercising in APP-HFD+Ex 0–
10 mice and APP-HFD+Ex 5–15 mice, although it was not as
evident as that in APP-HFD+Ex 10–20 mice (Figure 2A). The
food intake of APP-HFD+Ex 10–20 mice was the same or mildly
increased compared with that of APP-HFD+Ex 0–10 mice and
APP-HFD+Ex 5–15 mice (Figure S1), indicating that the atten-
uation of body weight in APP-HFD+Ex 10–20 mice was not
caused by reduction of food intake. Fasting glucose levels in APP-
HFD+Ex 0–10 mice and APP-HFD+Ex 5–15 mice were not
different from those in APP-HFD mice, which were higher than
that in APP-HFD+Ex 10–20 mice (Figure 2B. pre). Glucose
tolerance ability was clearly deteriorated in APP-HFD+Ex 0–10
mice and APP-HFD+Ex 5–15 mice compared with that in APP-
HFD+Ex 10–20 mice (Figure 2B). Insulin levels were not different
among APP-HFD mice, APP-HFD+Ex 0–10 mice, APP-HFD+Ex
5–15 mice and APP-HFD+Ex 10–20 mice (Figure 2C). Impor-
tantly, running distances in APP-HFD+Ex 0–10 mice and APP-
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HFD+Ex 5–15 mice were longer than those in APP-HFD+Ex 10–
20 mice (Figure 2D), indicating that the deterioration of glucose
metabolism in APP-HFD+Ex 0–10 mice and APP-HFD+Ex 5–15
mice was not caused by reduction of physical activity. We also
examined HFD-induced metabolic changes in WT mice that were
subjected to exercise. As in APP transgenic mice, HFD after
finishing exercise increased body weight (Figure 2E) and reduced
glucose tolerance (Figure 2F and G) in WT-HFD+Ex 0–10 mice
and WT-HFD+Ex 5–15 mice. Collectively, these results indicated
that HFD after exercising might abolish the effects of exercise in
maintaining reduced body weight and improving glucose intoler-
ance.
Effect of exercise on memory function was not abolished
by HFD in WT but in APP transgenic mice
To examine whether HFD after exercising abolished the
positive effect of exercise on memory function, we conducted
Morris water maze test on the mice 20 weeks after having HFD.
During the acquisition phase, the acquisition time was equally
improved in WT-HFD+Ex 0–10 mice, WT-HFD+Ex 5–15 mice
and WT-HFD+Ex 10–20 mice (Figure 3A, upper). In the probe
trial phase, the time to get to goal position in WT-HFD+Ex 0–10
mice and that in WT-HFD+Ex 5–15 mice was the same as that in
WT-HFD+Ex 10–20 mice, but it was shorter than that in WT-
HFD mice (Figure 3B, left). Also, the time in goal quadrant in
WT-HFD+Ex 0–10 mice and that in WT-HFD+Ex 5–15 mice
was the same as that in WT-HFD+Ex 10–20 mice, but it was
longer than that in WT-HFD mice (Figure 3C, left). These results
suggested that WT mice might remain the effect of exercise on
memory function even if they kept having HFD after exercising. In
contrast, the time to get to goal position in APP-HFD+Ex 0–10
mice and that in APP-HFD+Ex 5–15 mice was significantly longer
than that in APP-HFD+Ex 10–20 mice, but it was the same as that
in APP-HFD mice (Figure 3B, right). Besides, the time in goal
quadrant in APP-HFD+Ex 0–10 mice and that in APP-HFD+Ex
5–15 mice was shorter than that in APP-HFD+Ex 10–20 mice, but
it was the same as that in APP-HFD mice (Figure 3C, right).
Notably, locomotor activities were not affected by different periods
of exercise as exhibited by swimming speeds (Figure S2).
Additionally, to examine whether exercise during weeks 0–10
and 5–15 actually improved memory function, we randomly
selected two mice from each group- APP-HFD+Ex 0–10 mice,
APP-HFD+Ex 5–15 mice and APP-HFD+Ex 10–20 mice- and
examined their memory function at the time points 10 or 15 weeks
after having HFD (Figure S3). Exercise during weeks 0–10 and 5–
15 might be able to enhance memory function in APP-HFD mice.
These results collectively indicated that consumption of HFD after
finishing exercise could disrupt the positive effect of exercise on
memory function in APP transgenic mice, but not in WT mice.
Improvement of Ab pathology by exercise was abolished
by HFD in APP transgenic mice
As shown in our previous report, HFD aggravated the
oligomerization and accumulation of Ab, whereas a marked
reduction of the same was observed in APP-HFD+Ex 10–20 mice
[10]. Immunohistochemical analysis showed that the accumulated
Ab level in APP-HFD+Ex 0–10 mice was higher than that in APP-
HFD+Ex 10–20 mice (Figure 4A). ELISA also showed that the Ab
40 level in FA fraction of APP-HFD+Ex 0–10 mice was higher
than that of APP-HFD+Ex 10–20 mice (Figure 4B). There was no
difference between the levels of Ab 42 in APP-HFD+Ex 0–10 and
in APP-HFD+Ex 10–20 mice (Figure 4C). Both Ab 40 and Ab 42
levels in APP-HFD+Ex 0–10 were lower than those in APP-HFD
mice (Figure 4B and C). TBS-soluble Ab oligomers are known as
the most toxic form of Ab correlating with memory deficits in AD
model mice [18–20]. ELISA showed that the level of Ab oligomer
in APP-HFD+Ex 0–10 was significantly higher than that in APP-
HFD+Ex 10–20 mice (Figure 4D). Filter trap analysis using anti-
Figure 1. Exercise treatment given to APP-HFD mice at different time periods. Schematic presentation of the exercise treatment given to
APP-HFD mice. Female APP transgenic mice were maintained on standard diet in standard laboratory cages until they were 2–3 months old. Then,
the mice were separated into 5 groups. In the control group, the mice were fed with a standard diet in standard laboratory cages for 20 weeks
(control APP mice) (top row, n = 5). In the HFD-induced group, the mice were fed HFD in standard laboratory cages for 20 weeks (APP-HFD mice) (2nd
row, n = 5). In the exercise-induced group during weeks 10 to 20 of HFD, the mice spent 10 weeks in standard laboratory cages, and then spent
10 weeks in enrichment cages in the presence of HFD (APP-HFD+Ex 10–20 mice) (3rd row, n = 6). As novel interventions, in the exercise-induced
group during 5 to 15 weeks of HFD, the mice spent 5 weeks in standard laboratory cages, 10 weeks in enrichment cages, and then 5 weeks in
standard laboratory cages in the presence of HFD (APP-HFD+Ex 5–15 mice) (4th row, n= 7). In the exercise-induced group on 0 to 10 weeks of HFD,
the mice spent 10 weeks in enrichment cages, and then spent 10 weeks in standard laboratory cages in the presence of HFD (APP-HFD+Ex 0–10
mice) (5th row, n = 8). After 20 weeks, metabolic conditions of these mice were analyzed, followed by ethological, histochemical and biochemical
analyses targeting AD pathophysiology.
doi:10.1371/journal.pone.0072796.g001
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oligomer antibody to detect oligomeric Ab species also showed the
same tendency in the amount of Ab oligomer by ELISA assay
(Figure 4E). Interestingly, the level of Ab oligomer in APP-
HFD+Ex 0–10 was the same as that in APP-HFD mice (Figure 4D
and E). The amount of Ab in FA fraction as well as Ab oligomer in
APP-HFD+Ex 5–15 mice were at intermediate levels between
those in APP-HFD+Ex 0–10 mice and in APP-HFD+Ex 10–20
mice. These results collectively indicated that HFD after finishing
exercise might revive the level of soluble Ab oligomers.
APP-CTFb was accumulated in the APP mice having HFD
after finishing exercise
From the above results, we wondered whether the level of Ab
oligomers in our mice was regulated by APP processing or by Ab
degradation. In order to investigate the effect of HFD after
exercising on APP processing, we analyzed the level of APP C-
terminus fragment (CTF) b through immunoblotting assay. a- and
b-secretases cleave APP at the extramembrane domain, producing
APP-CTFa and APP-CTFb respectively. c-Secretase then cleaves
Figure 2. HFD after finishing exercise deteriorated glucose tolerance in APP-HFD mice. (A) Relative body weight changes over 20 weeks
in control APP, APP-HFD, APP-HFD+Ex 0–10, APP-HFD+Ex 5–15 and APP-HFD+Ex 10–20 mice. The body weight 2 weeks before each diet was
regarded as the baseline (0 g). (B) Blood glucose levels during glucose tolerance test after an intra-peritoneal injection of glucose (2 g/kg body
weight). Fasting glucose levels in APP-HFD+Ex 0–10 mice (F (4, 20) = 9.03, p,0.001) and in APP-HFD+Ex 5–15 mice (p = 0.006) were higher than those
in APP-HFD+Ex 10–20 mice. Glucose tolerance abilities in APP-HFD+Ex 0–10 mice (F (4, 60) = 16.17, p,0.001) and in APP-HFD+Ex 5–15 mice (p,0.001)
were worse than those in APP-HFD+Ex 10–20 mice. The glucose tolerance in APP-HFD mice was the same as those in APP-HFD+Ex 0–10 mice and
APP-HFD+Ex 5–15 mice. n.s. indicated not significant. * indicated p,0.05. (C) Blood insulin levels during fasting. Plasma insulin levels in APP-HFD+Ex
0–10 mice and in APP-HFD+Ex 5–15 mice were not different from those in APP-HFD+Ex 10–20 mice (F (4, 20) = 2.22). * indicated p,0.05. (D) Average
running distance using a running wheel per day (m/day). Running distance was estimated from the number of running wheel rotations. The lengths
in APP-HFD+Ex 0–10 mice (F (2, 12) = 7.61, p = 0.003) and in APP-HFD+Ex 5–15 mice (p = 0.008) were significantly longer than those in APP-HFD+Ex 10–
20 mice. * indicated p,0.05. (E) Relative body weight changes over 20 weeks in control WT, WT-HFD, WT-HFD+Ex 0–10, WT-HFD+Ex 5–15 and WT-
HFD+Ex 10–20 mice. The body weight 2 weeks before each diet was regarded as the baseline (0 g). (F) Blood glucose levels during glucose tolerance
test after an intra-peritoneal injection of glucose (2 g/kg body weight). Fasting glucose levels in WT-HFD+Ex 0–10 mice (F (4, 10) = 12.72, p = 0.006) and
in WT-HFD+Ex 5–15 mice (p,0.001) were higher than that in WT-HFD+Ex 10–20 mice. Glucose tolerance abilities in WT-HFD+Ex 0–10 mice (F (4, 30)
= 29.98, p,0.001) and in WT-HFD+Ex 5–15 mice (p,0.001) were lower than that in WT-HFD+Ex 10–20 mice. n.s. indicated not significant. * indicated
p,0.05. (G) Insulin levels during fasting. Insulin levels in WT-HFD+Ex 0–10 mice and in WT-HFD+Ex 5–15 mice were not different from that in WT-
HFD+Ex 10–20 mice (F (4, 10) = 7.24).
doi:10.1371/journal.pone.0072796.g002
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APP-CTFa and APP-CTFb at the intramembrane domain,
producing p3 and Ab respectively. The level of APP-CTFb in
APP-HFD+Ex 0–10 mice was higher than that in APP-HFD+Ex
10–20 mice, although it did not reach the level where it could be
considered statistically significant (Figure 5A). The level of APP-
CTFb in APP-HFD+Ex 5–15 mice was at intermediate level
between that in APP-HFD+Ex 0–10 mice and in APP-HFD+Ex
10–20 mice. This result indicated that HFD after finishing exercise
might promote the cleavage of APP by b-secretase, followed by the
accumulation of APP-CTFb˜ Next, we examined the effect of HFD
after exercising on Ab degradation. Since we have previously
reported that exercise strengthens the enzymatic activity of
neprilysin, an Ab-degrading protease, in APP-HFD mice [11],
we conducted in vitro neprilysin activity assay. Notably, the
enzymatic activity of neprilysin in APP-HFD+Ex 0–10 mice or
in APP-HFD+Ex 5–15 mice was the same as that in APP-
HFD+Ex 10–20 mice (Figure 5B). This result indicated that HFD
for 10 weeks was not sufficient to abolish the exercise-induced up-
regulation of neprilysin activity.
Discussion
Many reports have focused on the pathological roles of familial
genes as a contributory factor in AD and their functions have been
clarified gradually. On the other hand, increasing reports have
recently examined the effects of environmental factors on AD
pathology [21–29]. Importantly, epidemiological and experimen-
tal reports have shown that metabolic conditions caused by high
caloric intake constitute an important risk factor in the develop-
ment of sporadic AD [21,22,25]. Consistent with these back-
grounds, it has been demonstrated that feeding HFD to APP mice
shows significant deterioration of memory function [7]. It has also
been shown that voluntary exercise is effective in the improvement
of HFD-induced Ab deposition and memory deficit [10]. In the
present study, we showed the novel finding that the beneficial
effect of exercise on memory function could last for a long time in
WT mice, whereas it was immediately abolished in APP transgenic
mice if they continued to take HFD after finishing exercise.
It has been proposed that hyperglycemia causes damage to
neurons due to increase in the reactive oxygen species [30]. Also,
Figure 3. Effect of exercise on memory function was abolished by HFD in APP transgenic mice. (A) The time to get to goal platform of
exercise-treated WT-HFD mice (upper) and APP-HFD mice (lower) in the acquisition phase of Morris water maze test, 20 weeks after having HFD. WT-
HFD+Ex 0–10 mice and WT-HFD+Ex 5–15 mice took the same time to get to the platform as WT-HFD+Ex 10–20 mice. Also, APP-HFD+Ex 0–10 mice
and APP-HFD+Ex 5–15 mice tended to take longer than APP-HFD+Ex 10–20 mice to get to the platform; however, this was statistically insignificant.
(B) Time taken to get to goal position of exercise-treated WT-HFD mice (left) and APP-HFD mice (right) in the probe trial phase of Morris water maze
test, 20 weeks after having HFD. WT-HFD+Ex 0–10 mice (F (4, 10) = 18.63, p,0.001) and WT-HFD+Ex 5–15 mice (p,0.001) took less time to reach the
platform position than WT-HFD mice, but they took the same time as WT-HFD+Ex 10–20 mice. On the other hand, APP-HFD+Ex 0–10 mice (F (4, 20)
= 7.89, p,0.001) and APP-HFD+Ex 5–15 mice (p = 0.006) took longer to get to platform position than APP-HFD+Ex 10–20 mice. The time taken by
APP-HFD+Ex 0–10 mice and APP-HFD+Ex 5–15 mice was the same as that by APP-HFD mice. * indicated p,0.05. (C) Time in goal quadrant of
exercise-treated WT-HFD mice (left) and APP-HFD mice (right) in the probe trial phase of Morris water maze test, 20 weeks after having HFD. WT-
HFD+Ex 0–10 mice (F (4, 10) = 46.97, p,0.001) and WT–HFD+Ex 5–15 mice (p,0.001) spent more time in goal quadrant than WT-HFD mice, but spent
the same time in goal quadrant as WT-HFD+Ex 10–20 mice. On the other hand, APP-HFD+Ex 0–10 mice (F (4, 20) = 7.09, p = 0.003) and APP-HFD+Ex 5–
15 mice (p = 0.003) spent less time in goal quadrant than APP-HFD+Ex 10–20 mice. The time for APP-HFD+Ex 0–10 mice and APP-HFD+Ex 5–15 mice
was the same as that for APP-HFD mice. * indicated p,0.05.
doi:10.1371/journal.pone.0072796.g003
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HFD may lead to chronic cerebral hypoperfusion, which induces
impairment of working memory [31]. HFD may also lead to a
breakdown of the blood-brain barrier, resulting in the leakage of
serum-derived components into the brain parenchyma, leading to
neuronal dysfunction [32]. They might lead to memory impair-
ment in WT-HFD mice. Actually, obesity and glucose intolerance
were clearly observed in WT-HFD+Ex 0–10 and WT-HFD+Ex
5–15 mice (Figure 2), indicating that HFD after finishing exercise
disrupted metabolic conditions, which might also damage
neuronal functions in these mice. However, in the present study,
we showed that the beneficial effect of exercise on memory
function was maintained in WT-HFD mice even though they
stopped exercising (Figure 3). As a mechanism, we estimated that
the beneficial roles of exercise might keep counteracting HFD-
induced neuronal damages (i.e. from reactive oxygen species) in
WT-HFD mice. According to previous reports, exercise enhances
neurogenesis and increases the number of synapses [9]. Besides,
exercise regulates neuronal development as well as plasticity [33].
Therefore, the pathways up-regulated by exercise might be
different from those down-regulated by HFD.
Figure 4. HFD after exercising increased Ab oligomer as well as deposited Ab levels in APP-HFD mice. (A) Immunohistochemical analysis
using anti-Ab (6E10) antibody. Representative images of Ab-immunostained hippocampus sections from control APP, APP-HFD, APP-HFD+Ex 0–10,
APP-HFD+Ex 5–15 and APP-HFD+Ex 10–20 mice, respectively. Scale bar, 0.5 mm. Increase of Ab deposition was observed in APP-HFD+Ex 0–10and
APP-HFD+Ex 5–15 mice compared with that in APP-HFD+Ex 10–20 mice. However, the amount of Ab deposition in APP-HFD+Ex 0–10 mice and APP-
HFD+Ex 5–15 mice was less than that in APP-HFD mice. (B) The amount of Ab 40 in FA fraction of control APP, APP-HFD, APP-HFD+Ex 0–10, APP-
HFD+Ex 5–15 and APP-HFD+Ex 10–20 mice was analyzed by ELISA. Ab 40 level in FA fraction of APP-HFD+Ex 0–10 mice was higher than that of APP-
HFD+Ex 10–20 mice (F (4, 15) = 10.40, p = 0.009). However, the amount of Ab 40 in APP-HFD+Ex 0–10 mice (p = 0.028) and APP-HFD+Ex 5–15 mice
(p = 0.004) was less than that in APP-HFD mice. * indicated p,0.05. (C) The amount of Ab 42 in FA fraction of control APP, APP-HFD, APP-HFD+Ex 0–
10, APP-HFD+Ex 5–15 and APP-HFD+Ex 10–20 mice was analyzed by ELISA. There was no statistically significant difference in the level of Ab 42
among APP-HFD+Ex 0–10, APP-HFD+Ex 5–15 and APP-HFD+Ex 10–20 mice (F (4, 15) = 24.4). However, the amount of Ab 42 in APP-HFD+Ex 0–10 mice
(p,0.001) and APP-HFD+Ex 5–15 mice (p,0.001) was lower than that in APP-HFD mice. * indicated p,0.05. (D) The amount of Ab oligomer in the
TBS-soluble fraction of control APP, APP-HFD, APP-HFD+Ex 0–10, APP-HFD+Ex 5–15 and APP-HFD+Ex 10–20 mice was analyzed by ELISA. The level of
Ab oligomer in TBS fraction of APP-HFD+Ex 0–10 mice was higher than that of APP-HFD+Ex 10–20 mice (F (4, 15) = 3.33, p = 0.035). The amount of Ab
oligomer in APP-HFD+Ex 0–10 mice was the same as that in APP-HFD mice. * indicated p,0.05. (E) The amount of Ab oligomer in the TBS-soluble
fraction of control APP, APP-HFD, APP-HFD+Ex 0–10, APP-HFD+Ex 5–15 and APP-HFD+Ex 10–20 mice was analyzed by filter trap assay using anti-
oligomer (A11) antibody to detect oligomeric Ab. Representative images of dot are shown in upper panel. Statistical analysis of dot density is
described at the bottom. The average dot density of the control APP samples was regarded as 100% and that of other groups was relatively indicated.
The relative density of APP-HFD+Ex 0–10 mice was higher than that of APP-HFD+Ex 10–20 mice (F (4, 10) = 12.69, p = 0.007). The dot density of Ab
oligomer in APP-HFD+Ex 0–10 mice was the same as that in APP-HFD mice. * indicated p,0.05.
doi:10.1371/journal.pone.0072796.g004
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On the other hand, APP-HFD mice show more significant
memory impairment than WT-HFD mice [10], suggesting that the
memory impairment in APP-HFD mice was attributable to an
interaction between HFD and APP metabolism. In the present
study, exercise during early periods was able to inhibit HFD-
induced memory impairment in APP-HFD mice (Figure S3).
However, the beneficial effect of exercise on memory function was
immediately abolished in APP-HFD mice when they kept having
HFD after exercising (Figure 3). We observed that toxic Ab
oligomer level in APP-HFD+Ex0–10 mice was the same as that in
APP-HFD mice. We also observed that the level of deposited Ab
in APP-HFD+Ex0–10 mice was lower than that in APP-HFD
mice (Figure 4). Since the degree of memory impairment in APP-
HFD+Ex0–10 mice was the same as that in APP-HFD mice, we
speculated that the increase of soluble Ab oligomer by HFD after
finishing exercise might be sufficient to lead to memory loss. Then
we examined the molecular mechanisms, based on which HFD
after exercising increased Ab oligomer level. In our previous
report, we demonstrated that HFD may promote the cleavage of
APP by b-secretase leading to the production of Ab, but exercise
inhibited it. As a mechanism, we have demonstrated that HFD
leads to metabolic conditions such as obesity and glucose
abnormalities, followed by up-regulating b-secretase enzyme
activity. But exercise can down-regulate b-secretase enzyme
activity since it improves HFD-induced metabolic condition
[10]. In the present study, we showed that HFD might increase
the level of APP-CTFb after finishing exercise (Figure 5). Thus,
once exercise is finished, HFD might rapidly re-increase APP
processing. In this sense, the effect of exercise on the inhibition of
b-secretase activity might be temporary. We had recently shown
that exercise strengthens the enzymatic activity of neprilysin,
which may promote the degradation of Ab [11]. However, in the
present study, we showed that HFD after exercising did not lower
neprilysin activity (Figure 5). According to these results, we
speculated that HFD-promoted Ab production might be the
reason why HFD after finishing exercise increased Ab oligomer as
well as deposited Ab. However, previous literature has reported
that HFD suppresses the activity of insulin-degrading enzyme [7].
Figure 5. HFD after finishing exercise promoted APP CTFb accumulation in APP-HFDmice. (A) Immunoblotting analysis of APP full length
and APP-CTFb using APP C-terminus antibody. The number of animals used for immunoblotting analysis is 3–4 per group. Statistical analysis is shown
in the right panel. The band of APP CTFb was normalized by that of APP full length. The band density of the control APP mice was regarded as 100%
and that of other groups was relatively indicated. The band density of APP CTFb in APP-HFD+Ex 0–10 mice tended to be higher compared with that
in APP-HFD+Ex 10–20 mice (F (4, 13) = 3.70, p = 0.070). * indicated p,0.05. (B) In vitro enzyme activity assay of neprilysin using fluorescent substrate.
The activity of neprilysin in APP-HFD+Ex 0–10 or APP-HFD+Ex 5–15 mice was not different from that in APP-HFD+Ex 10–20 mice (F (4, 15) = 4.10). *
indicated p,0.05.
doi:10.1371/journal.pone.0072796.g005
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Thus, the effects of another Ab-degrading enzyme on our results
should be clarified in future studies.
Verret et al. have reported that in WT mice, an enriched
environment during earlier period has the same effect on memory
function as later one under a standard diet condition [34].
Although there is a discrepancy between their experimental setting
and ours, we consistently showed that the effect of exercise on
memory was maintained even under a HFD condition in WT
mice (Figure 3). Verret et al. have also shown that an enriched
environment during earlier period is more effective in reserving
memory function than that during later period in APP transgenic
mice having standard diet [34]. However, we showed that the
effect of exercise during earlier period on memory function was
clearly reduced 20 weeks after having HFD (Figure 3). In this
sense, whether the effect of exercise is maintained might depend
on the metabolic conditions in APP transgenic mice. However,
there was a limitation in the experiment using APP transgenic
mice. In this report, we showed that only 10 weeks of HFD after
finishing exercise was sufficient to increase Ab oligomer level and
subsequently, to disrupt exercise-protected memory function. This
rapid alteration might be due to the experimental strategy using
transgenic model mice overexpressing APP and producing excess
amount of Ab. In fact, a previous study using in vivo multiphoton
microscopy has reported that Ab plaques form extraordinarily
quickly, over 24 hours, in model mice of AD [35]. Such a rapid
alteration of Ab deposition may not be relevant in sporadic human
AD cases. Considering this discrepancy between APP transgenic
mice and human AD cases, it is not clear whether HFD abolishes
the beneficial effect of exercise on memory function in human
cases as rapidly as in APP transgenic mice. Nevertheless, our
findings clearly indicate that continuation of exercise is necessary
to rescue HFD-induced aggravation of cognitive decline in APP
transgenic mice. Given that the effect of exercise depends on
metabolic conditions, one’s dietary pattern should be considered a
very important factor in the prevention of AD.
Supporting Information
Figure S1 Every week monitoring of the amount of food
intake. Every week monitoring showed that average amount of
food intake in control APP, APP-HFD, APP-HFD+Ex 0–10, APP-
HFD+Ex 5–15 and APP-HFD+Ex 10–20 mice. During the
induction of exercise, APP-HFD+Ex 0–10, APP-HFD+Ex 5–15
and APP-HFD+Ex 10–20 mice tended to take more food than
APP-HFD mice did.
(PDF)
Figure S2 Swimming speeds in Morris water maze test.
Locomotor activities of control APP, APP-HFD, APP-HFD+Ex 0–
10, APP-HFD+Ex 5–15 and APP-HFD+Ex 10–20 mice were
analyzed by swimming speeds in the visual cue phase of Morris
water maze tests 10, 15 (A) and 20 weeks (B) after having HFD.
There were no statistical differences among control APP, APP-
HFD, APP-HFD+Ex 0–10, APP-HFD+Ex 5–15 and APP-
HFD+Ex 10–20 mice.
(PDF)
Figure S3 Exercise at different periods were able to
strengthen memory function in APP-HFD mice. 10 weeks
after having HFD, the acquisition time was clearly shortened in
APP-HFD+Ex 0–10 mice (Figure S3B, left). Furthermore,
15 weeks after having HFD, the acquisition time was also
ameliorated in APP-HFD+Ex 5–15 mice (Figure S3B, right).
These results indicated that exercise during weeks 0–10 and
weeks 5–15 could strengthen memory function in APP-HFD mice.
However, at 10 weeks after having HFD, the improvement in the
acquisition time was not observed in APP-HFD+Ex 10–20 mice,
indicating that HFD for 10 weeks was sufficient to induce memory
loss in APP transgenic mice (Figure S3B, left). We also conducted
the pilot study in WT-HFD mice using the same strategy in APP-
HFD mice. Although HFD for 10 weeks was sufficient to lead to
memory deficit in APP transgenic mice, HFD for 10 weeks did not
induce memory impairment in WT mice (Figure S3C). (A)
Schematic presentation of the pilot study in Morris water maze
test. Morris water maze test was conducted 10 weeks and
15 weeks after having HFD. (B) The time to get to the goal
platform of exercise-treated APP-HFD mice in the acquisition
phase, 10 weeks (left) and 15 weeks (right) after having HFD.
10 weeks after having HFD, APP transgenic mice having HFD
(APP-HFD+Ex 10–20 mice) took significant longer time to the
platform. On the other hand, APP-HFD+Ex 0–10 mice clearly
took shorter time to the platform than APP-HFD+Ex 10–20 mice.
(C) The time to get to the goal platform of exercise-treated WT-
HFD mice in the acquisition phase, 10 weeks (left) and 15 weeks
(right) after having HFD. 10 weeks after having HFD, WT mice
having HFD (WT-HFD+Ex 10–20 mice) did not take longer time
to the platform. WT-HFD+Ex 0–10 mice took the same time to
the platform as WT-HFD+Ex 10–20 mice.
(PDF)
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